Beneski Benjamin Machinas 4
4 · Allogene Therapeutics, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Beneski Benjamin Machinas
SVP, Chief Technical Officer
Transactions
- Award
Common Stock
2025-03-01+31,755→ 223,995 total - Award
Stock Option (Right to buy)
2025-03-01+112,339→ 112,339 totalExercise: $1.80Exp: 2035-03-01→ Common Stock (112,339 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.